Skip to main content
. Author manuscript; available in PMC: 2011 Mar 10.
Published in final edited form as: Cytotherapy. 2011 Feb;13(2):227–236. doi: 10.3109/14653249.2010.491611

Table 2.

Testing data for CAD patients at baseline and following completion of exercise program

Parameter Baseline (N = 10) Completion (N =10)
Vital Signs
 Body Mass Index (kg/m2) 27.9 ± 5.9 27.9 ± 5.9
 Systolic Blood Pressure (mmHg) 124 ± 15 124 ± 13
 Diastolic Blood Pressure (mmHg) 76 ± 10 73 ± 10
 Resting Heart Rate (beats/min) 74 ± 15 73 ± 10
Lab Values
 Total Cholesterol (mg/dL) 128 ± 24 130 ± 22
 Low-density Lipoprotein Cholesterol (mg/dL) 72 ± 26 72 ± 21
 High-density Lipoprotein Cholesterol (mg/dL) 45 ± 7 45 ± 7
 Triglycerides (mg/dL) 127 ± 51 122 ± 49
 C-Reactive Protein (mg/dL) 2.0 ± 3.5 2.3 ± 3.4
 Fasting Glucose (mg/dL) 113 ± 28 117 ± 28
 Hemoglobin (g/uL) 13.9 ± 1.3 13.9 ± 1.2
 White Blood Cells (K/uL) 6.0 ± 1.7 6.2 ± 1.2
 Neutrophils (%) 57.6 ± 8.0 59.2 ± 7.3
 Lymphocytes (%) 29.7 ± 8.6 28.4 ± 7.5
 Monocytes (%) 8.3 ± 1.9 8.3 ± 1.9
Exercise Data
 Exercise Duration (sec) 478 ± 174 526 ± 168
CD133 + (cells/mL) 873 ± 556 1666 ± 1747